¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nasal Allergy Symptom Control Nasl"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® epistaxis, nasal bleeding ÇÑ±Û ÄÚÇÇ, ºñÃâÇ÷
¼³¸í   
  ºñÃâÇ÷À̶õ ¸»±×´ë·Î ÄÚ¿¡¼­ Çǰ¡ ³ª´Â °ÍÀÌ´Ù. ÀÌ ÄÚÇÇ¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖ´Ù. ÀϹÝÀû ¿øÀÎÀ¸·Î´Â Ç÷¾×º´, ¼øÈ¯±âº´, °í¿­, ±â¾ÐÀÇ º¯È­ µîÀ» µé ¼ö ÀÖ°í ¿ù°æÀ̳ª ³úÃâÇ÷ÀÇ ´ë»óÀ¸·Î ³ª¿À´Â Àϵµ ÀÖÀ¸³ª, ½ÇÁ¦·Î´Â ±¹¼ÒÀû ¿øÀÎÀÌ ÈξÀ ¸¹Àº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±¹¼ÒÀû ¿øÀÎÀ¸·Î´Â ¿øÀÎÀ» ¾Ë ¼ö ¾ø´Â Æ¯¹ß¼º ºñÃâÇ÷ÀÌ °¡Àå ¸¹°í, ¿Ü»ó, ¿°Áõ, ¾ÏµîÀÌ ¿øÀÎÀϼö ÀÖ´Ù. ÃâÇ÷Àº ¾à 90%°¡ ºñÁß°ÝÀÇ Àü´Ü¿¡ Àִ Ű¼¿¹ÙÈå¾ó±â(Kiesselbach's plexus)¿¡¼­ ³ª¿Â´Ù. À̰÷Àº ¿©·¯ °¡Áö µ¿¸ÆÀÌ ¸ð¿© Àִ °÷À¸·Î ¿ø·¡ Ç÷·ù°¡ ¸¹¾Æ ÃâÇ÷ÀÇ ¼ÒÁö°¡ ¸¹Àº °÷ÀÌ´Ù. ³ª¸ÓÁö 10%´Â ÄÚ¾ÈÀÇ ´Ù¸¥ ºÎÀ§¿¡¼­ ³ª¿Ã ¼ö ÀÖ°í, Æ¯È÷ µÞºÎºÐ¿¡¼­ ³ª¿À´Â °æ¿ì´Â ÀÔÀ¸·Î Çǰ¡ Èê·¯³»¸®°í, È®½ÇÇÑ ÃâÇ÷ ºÎÀ§¸¦ Á¤È®È÷ °üÂûÇÒ ¼ö ¾ø´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ °£´ÜÇÑ Ä¡·á·Î´Â ÇذáµÇÁö ¾Ê´Â ¶§°¡ ¸¹´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • characteristic symptom
    Ư¡Áõ»ó
  • delayed symptom
    Áö¿¬Áõ»ó
  • dissociation symptom
    ÇØ¸®Áõ»ó
  • equivocal symptom
    ¸ðÈ£Áõ»ó
  • general symptom
    Àü½ÅÁõ»ó
  • induced symptom
    À¯¹ßÁõ»ó
  • local symptom
    ±¹¼ÒÁõ»ó
  • negative symptom
    À½¼ºÁõ»ó
  • objective symptom
    °´°üÁõ»ó, Ÿ°¢Áõ»ó
  • positive symptom
    ¾ç¼ºÁõ»ó
  • presenting symptom
    ¹ßÇöÁõ»ó
  • prodromal symptom
    Àü±¸Áõ»ó
  • pathognomonic symptom
    Áúº´Æ¯À¯Áõ»ó
  • subjective symptom
    ÁÖ°üÁõ»ó, ÀÚ°¢Áõ»ó
  • symptom
    Áõ»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • psychotic symptom
    Á¤½Åº´Áõ»ó
  • signal symptom
    °æ°íÁõ»ó
  • subjective symptom
    ÀÚ°¢Áõ»ó
  • withdrawal symptom
    ±Ý´ÜÁõ»ó
  • nasal bone
    ÄÚ»À
  • nasal bridge
    Äàµî
  • nasal cannula
    ÄÚ»ðÀÔ°ü
  • nasal cavity
    ÄÚ¾È, ºñ°­
  • nasal flaring
    ÄÚ¹ú··ÀÓ
  • nasal meatus
    Äà±æ
  • nasal
    ÄÚ-
  • nasal packing
    ÄÚ¸Þ¿ì±â
  • nasal speculum
    ÄÚº¸°³, ºñ°æ
  • nasal septum
    ÄÚÁß°Ý, ºñÁß°Ý
  • nasal tip
    ÄÚ³¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • characteristic symptom
    Ư¼ºÁõ»ó
  • concomitant symptom
    ¼ö¹ÝÁõ»ó
  • constitutional symptom
    Àü½ÅÁõ»ó
  • cutaneous symptom
    ÇǺÎÁõ»ó
  • symptom cluster
    Áõ»ó±º
  • delayed symptom
    Áö¿¬Áõ»ó
  • dissociation symptom
    ÇØ¸®Áõ»ó
  • equivocal symptom
    ºÎÁ¤Áõ»ó
  • febrile symptom
    ¿­Áõ»ó
  • first-rank symptom
    ÀϱÞÁõ»ó
  • general symptom
    (¢¡constitutional symptom) Àü½ÅÁõ»ó
  • induced symptom
    À¯¹ßÁõ»ó
  • initial symptom
    ÃʱâÁõ»ó
  • keynote symptom
    ÁÖ¿äÁõ»ó
  • local symptom
    ±¹¼ÒÁõ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • premonitory symptom
    Àü
  • presenting symptom
    ÁÖÁõ»ó(ñ«ñøßÒ).
  • pressure symptom
    ¾Ð¹ÚÁõ»ó(äâÚÞñøßÒ).
  • pressure symptom
    ¾Ð¹ÚÁõ»ó(äâÚÞñøßÒ)
  • primary symptom
    ÀÏÂ÷¼º¡¡Áõ»ó
  • prodromal symptom
    Àü±¸Áõ»ó(îñÏÌñøßÒ).
  • prodromal symptom
    Àü±¸Áõ»ó£®
  • rainbow symptom
    È«·ûÁõ»ó(ûöëÌñøßÒ).
  • AGC (automatic gain control)
    ÀÚµ¿ °ÔÀÎ Á¶Àý
  • AGC (automatic gain control)
    ÀÚµ¿ (í»ÔÑ) °ÔÀÎ Á¶Àý (ðàï½), À̵æÀÚµ¿Á¶Àý
  • Control system
    Á¶Àý°è(ðàï½Í§)
  • Levey Jennings control chart
    ·¹ºñÁ¦´×½º°ü¸®µµ
  • Westgard quality control test
    ¿þ½ºÆ®°¡µåÁ¤µµ°ü¸®°Ë»ç¹ý
  • abdominal allergy =gastrointestinal a.
    ¼ÒÈ­¼º(á¼ûùàõ) ¾Ë·¹¸£±â.
  • accuracy control
    Á¤È®¼º Á¶Àý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • allergy, pollen
    È­ºÐ ¾Ë·¹¸£±â, ²É°¡·ç ¾Ë·¹¸£±â
  • allergy, psychogenic
    ½ÉÀμº ¾Ë·¹¸£±â, Á¤½Å¼º ¾Ë·¹¸£±â
  • atopic allergy
    ¾ÆÅäÇÇ(¼º) ¾Ë·¹¸£±â.
  • atopic allergy
    ¾ÆÅäÇǼº ¾Ë·¹¸£±â
  • bronchial allergy
    ±â°üÁö¾Ë·¹¸£±â
  • bronchial allergy
    ±â°üÁö¾Ë·¹¸£±â<¾Ë·¯Áö>.
  • congenital allergy<³ª> allergia congenita
    ¼±Ãµ¼º ¾Ë·¹¸£±â.
  • contact allergy
    Á¢Ã˼º ¾Ë·¹¸£±â
  • cutaneous allergy = skin a.
    ÇǺξ˷¹¸£±â
  • cutaneous allergy =skin a.
    ÇǺξ˷¹¸£±â.
  • delayed allergy = retarded a
    Áö¿¬¼º ¾Ë·¹¸£±â
  • delayed allergy =retarded a.
    Áö¿¬¼º ¾Ë·¹¸£±â.
  • drug (induced) allergy
    ¾à¹°(À¯¹ß) ¾Ë·¹¸£±â.
  • drug allergy
    ¾à¹°¾Ë·¯Áö, ¾à¹°(å·Úª) ¾Ë·¹¸£±â.
  • drug allergy
    ¾à¹°¾Ë·¯Áö, ¾à¹°(å·Úª)¾Ë·¹¸£±â.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • External nasal branches
    ¹Ù±ùÄÚ°¡Áö
    [¿¾ ¿ë¾î] ¿ÜºñÁö
  • External nasal vein
    ¹Ù±ùÄÚÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ÜºñÁ¤¸Æ
  • Nasal crest
    ºñ°­´É¼±
    [¿¾ ¿ë¾î] ºñ¸ª
  • Internal nasal branches
    ¼ÓÄÚ°¡Áö
    [¿¾ ¿ë¾î] ³»ºñÁö
  • Inferior posterior nasal branches
    ¾Æ·¡µÚÄÚ°¡Áö
    [¿¾ ¿ë¾î] ÇÏÈĺñÁö
  • Inferior nasal arteriole of retina
    ¾Æ·¡¾ÈÂʸÁ¸·¼Òµ¿¸Æ
    [¿¾ ¿ë¾î] Çϳ»Ãø¸Á¸·¼Òµ¿¸Æ
  • Inferior nasal venule of retina
    ¾Æ·¡¾ÈÂʸÁ¸·¼ÒÁ¤¸Æ
    [¿¾ ¿ë¾î] Çϳ»Ãø¸Á¸·¼ÒÁ¤¸Æ
  • Inferior nasal meatus
    ¾Æ·¡ÄÚ±æ
    [¿¾ ¿ë¾î] ÇϺñµµ
  • Inferior nasal concha
    ¾Æ·¡ÄÚ¼±¹Ý
    [¿¾ ¿ë¾î] ÇϺñ°©°³
  • Medial superior posterior nasal branches
    ¾ÈÂÊÀ§µÚÄÚ°¡Áö
    [¿¾ ¿ë¾î] ³»Ãø»óÈĺñÁö
  • Medial nasal branches
    ¾ÈÂÊÄÚ°¡Áö
    [¿¾ ¿ë¾î] ³»ÃøºñÁö
  • Medial nasal prominence
    ¾ÈÂÊÄÚÀ¶±â
    [¿¾ ¿ë¾î] ³»ÃøºñÀ¶±â
  • Anterior nasal spine
    ¾ÕÄÚ°¡½Ã
    [¿¾ ¿ë¾î] Àüºñ±Ø
  • Anterior nasal aperture
    ¾ÕÄ౸¸Û
    [¿¾ ¿ë¾î] Àüºñ°ø
  • Definitive posterior nasal nostril [Definitive choana]
    ¿Ï¼ºµÚÄ౸¸Û
    [¿¾ ¿ë¾î] ¿Ï¼ºÈĺñ°ø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • stringent control
    ¾ö°Ý Á¦¾î (åñÌ«ð¤åÙ)
  • transcriptional control
    Àü»ç Á¦¾î(ï®ÞÐð¤åÙ)
  • translational control
    ¹ø¿ª Á¶Àý(Ûèæ»ðàï½)
  • zero time control
    ¿µ½Ã(çÍãÁ) ´ëÁ¶(ÓßðÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • symptom
    Áõ»ó
  • symptom-complex
    ÁõÈıº
  • time gain control
    ½Ã°£°ÔÀÎÁ¶Àý
  • withdrawal symptom
    ±Ý´ÜÁõ»ó
  • nasal
    ÄÚÀÇ, ºñÀÇ, ºñÃøÀÇ
  • nasal airway
    °æºñÈ£Èí°ü
  • nasal atresia
    ºñ°­Æó¼â(Áõ)
  • nasal bleeding
    ºñÃâÇ÷
  • nasal polyp
    ºñÆú¸³(¿ëÁ¾)
  • nasal septal cartilage
    ÄÚÁß°Ý¿¬°ñ, ºñÁß°Ý¿¬°ñ
  • nasal septum
    ÄÚÁß°Ý, ºñÁß°Ý
  • nasal spine
    ºñ±Ø
  • nasal turbinate
    ºñ°©°³
  • proper nasal cavity
    °íÀ¯ºñ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AACIA American Association for Clinical Immunology and Allergy
ACAAI American College of Allergy, Asthma and Immunology
AI accidental injury; accidentally incurred; adiposity index; aggregation index; allergy and immunology...
A&I allergy and immunology
Al allantoic; allergic, allergy; aluminum
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OAS Oral Allergy Syndrome
CMPA cow milk protein allergy
Control control
control group control
FPANS Fluticasone Propionate Aqueous Nasal Spray
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • admission by legal control
    Á¶Ä¡ ÀÔ¿ø
  • birth control
    ÇÇÀÓ¹ý
    ¼öŸ¦ ÀΰøÀûÀ¸·Î Á¶ÀýÇÏ´Â ÀÏ. Àü¿¡´Â »ê¾Æ Á¦ÇÑ, Ãâ»ê Á¶ÀýÀ̶ó°í ÇßÀ¸³ª Á¶Àý ´ë»óÀº ºÐ¸¸ÀÌ ¾Æ´Ï°í ¼öÅÂÀ̱⠶§¹®¿¡ ¼öÅ Á¶Àý·Î °³Á¤µÇ¾ú´Ù. ¸ðüÀÇ °Ç°­À̳ª °æÁ¦ÀûÀÎ ÀÌÀ¯ µîÀ¸·Î ÀÓ½ÅÇØ¼­´Â °ï¶õÇÑ »çÁ¤ÀÌ ÀÖÀ» ¶§ ÇÇÀÓÀ» °è¼ÓÇϰí, ¾ÆÀ̰¡ ÇÊ¿äÇØÁö¸é ÇÇÀÓÀ» ÁßÁöÇϰí ÀÓ½ÅÇÒ ¼ö ÀÖµµ·Ï ÀÎÀ§ÀûÀÎ ¼ö´ÜÀ» »ç¿ëÇØ¼­ ¼öŸ¦ ÀΰøÀûÀ¸·Î Á¶ÀýÇÏ¿© »ê¾Æ¸¦ Á¦ÇÑÇÏ´Â °ÍÀÌ´Ù. ÀÌ¹Ì ÀÓ½ÅÇÑ °ÍÀ» ÀΰøÀûÀ¸·Î ÁßÀýÇÏ´Â °ÍÀº ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾Ê´Â´Ù. Áï, ÇÇÀÓÀÇ ½ÇÆÐ´Â µµ¸®°¡ ¾ø±â ¶§¹®¿¡ ¹Ù¸¥ ÇÇÀÓÀÇ Áö½ÄÀ» ¾ò¾î ÀûÀýÇÑ ÇÇÀÓ¹ýÀ» ¼±ÅÃÇØ¼­ ¹Ù¸£°Ô ½ÃÇàÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù. ¼öÅ Á¶Àý¿¡ ÀÀ¿ëµÇ´Â ÇÇÀÓ¹ýÀº ¼öÁ¤ ÀúÁö¹ý°ú ¼öÅ ÀúÁö¹ýÀ¸·Î ´ëº°µÇÁö¸¸ ¸ðµÎ ÀϽÃÀûÀÎ ÇÇÀÓ¹ýÀÌ´Ù. À̰ÍÀº ±¹°¡°¡ ÁÖüÀÎ °æ¿ì¿¡´Â Àα¸ Á¤Ã¥ÀÌ µÇ¸ç, °¡Á¤ÀÌ ÁÖüÀÎ °æ¿ì¿¡´Â °¡Á· °èȹÀÌ µÇ´Â °¡Àå ÇÕ¸®ÀûÀÎ ¼ö´ÜÀÌ´Ù. ½Ç¿ëÀûÀÎ ¸é¿¡¼­ ºÐ·ùÇÑ ÇÇÀÓ¹ýÀº ´ÙÀ½°ú °°´Ù. ¡¼¹è¶õÀÏ ÀüÈÄÀÇ ¼º±³¸¦ ÇÇÇÏ´Â ¹æ¹ý¡½ ¹è¶õÀÏ ÀüÈÄ ¼öÀϰ£À» ±Ý¿åÇÔÀ¸·Î½á ¼öÁ¤À» ¹Ì¸® ¸·´Â °ÍÀ¸·Î, ¹è¶õÀÏÀ» ¿¹»óÇÏ´Â ¹æ¹ý¿¡´Â 2°¡Áö°¡ ÀÖ´Ù. ¨ç ¿À±â³ë½Ä ¼öÅ Á¶Àý¹ý : Çѱ¹¿¡¼­ °¡Àå ³Î¸® º¸±ÞµÇ¾î ÀÖ´Â ¹æ¹ýÀ¸·Î, ¿ù°æ ÁֱⰡ Á¤È®ÇÏ°Ô µ¹¾Æ¿À´Â ¿©¼º¿¡°Ô¸¸ Àû¿ëÀÌ °¡´ÉÇÏ´Ù. 28ÀÏÇüÀÎ ¿©¼ºÀÇ °æ¿ì ¿ù°æ Á¦1ÀϰºÎÅÍ ¼¼¾î¼­ Á¦14Àϰ°¡ µÇ´Â ³¯ÀÇ Àü 3Àϰ£°ú ÈÄ 2Àϰ£ÀÌ °¡Àå ÀÓ½ÅÇϱ⠽¬¿î ³¯·Î º¸°í ÀÌ ±â°£Àº ¼º±³¸¦ ÇÇÇÑ´Ù. ÀÌ ¹æ¹ýÀº ¿ù°æ ÁֱⰡ ºÒ±ÔÄ¢ÇÑ ¿©¼ºÀÇ °æ¿ì¿¡´Â ½ÇÆÐÀÇ È®·üÀÌ Å©´Ù. ¨è ±âÃÊ Ã¼¿ÂÇ¥¸¦ ÀÀ¿ëÇÏ´Â ¹æ¹ý : ¸ÅÀÏ ±âÃÊ Ã¼¿ÂÀ» ÃøÁ¤Çؼ­ ±âÃÊ Ã¼¿Â °î¼±ÀÌ °í¿Â»óÀÌ µÇ¾î 2ÀÏÀÌ °æ°úÇßÀ» ¶§´Â °ÅÀÇ ÀÓ½ÅÇÏÁö ¾Ê´Â °ÍÀ¸·Î ³ªÅ¸³ª ÀÖ¾î 3ÀÏ ÀÌÈĺÎÅÍ ¼º±³¸¦ °®´Â ¹æ¹ýÀÌÁö¸¸, °í¿Â»óÀÎÁö Àú¿Â»óÀÎÁö¸¦ Á¤ÇϱⰡ ¶§·Î´Â °ï¶õÇÑ ¶§°¡ ÀÖ´Ù. ¡¼³²¼ºÀÌ ÇÇÀÓ µµ±¸³ª ¾àǰÀ» »ç¿ëÇÏ´Â ¹æ¹ý¡½ ³²¼ºÀÌ ¼º±³ ¶§ Äܵ¼À» ½á¼­ ¼öÁ¤À» ÀúÁöÇÏ´Â ¹æ¹ýÀÌ °¡Àå ÀϹÝÀûÀÌ´Ù. Äܵ¼Àº ³²¼º ¼º±â¿¡ ¾º¿ö¼­ »ç¿ëÇÏ´Â ¾ãÀº °í¹« Á¦Ç°ÀÎ Á¡¿¡¼­ ³²¼ºÀÌ »ç¿ë°¨À» °¡Áö°Ô ÇÑ´Ù´Â °áÁ¡ÀÌ ÀÖ°í, ¿©¼º¿¡°Ô´Â ½É¸®ÀûÀÎ ¹®Á¦¸¦ Æ÷ÇÔÇÏ¿© ¿©·¯ °¡Áö °áÁ¡ÀÌ ÁöÀûµÇ°í ÀÖÁö¸¸, ½ÇÆÐÀ²ÀÌ ³·°í ÀϹÝÀûÀ¸·Î ½±°Ô ±¸ÇÒ ¼ö ÀÖÀ¸¸ç ´©±¸³ª »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ´Ù¸¥ ¹æ¹ý¿¡ ºñÇØ ÀåÁ¡ÀÌ´Ù. ƯÈ÷ ÃÖ±Ù¿¡´Â °í¹«ÀÇ ÁúÀÌ °³·®µÇ°í Á¦Ç°ÀÇ Ç°ÁúÀÌ Çâ»óµÇ¾î ÆÄ¼ÕÀÇ ¿ì·Áµµ ¾ø´Ù. ÀÌ ¹Û¿¡ Á¤ÀÚ¸¦ ¸¸µå´Â ÈûÀ» ¾àÈ­½Ãų ¸ñÀûÀ¸·Î ³²¼º¿¡°Ô ÇÇÀÓ ¾àÀ» ¾²°Ô ÇÏ´Â °æ¿ìµµ ÀÖÀ¸³ª, ÇÇÀÓÀÇ ¸ñÀûÀº ´Þ¼ºÇß´Ù ÇØµµ °¡²û ³²¼ºÀÇ ¼º¿åÀ» ÀúÇϽÃŲ´Ù ÇÏ¿© ½Ç¿ëµÇÁö ¾Ê°í ÀÖ´Ù. ¡¼ÁßÀý ¼º±³¹ý¡½»çÁ¤ Àü¿¡ ¼º±³¸¦ Áß´ÜÇϰí Áú ¿ÜºÎ¿¡ »çÁ¤ÇÏ´Â ¹æ¹ýÀε¥ Áú ¾È¿¡ Á¤¾×À» µé¿©º¸³»Áö ¾Êµµ·Ï ÇØ¼­ ÀÓ½ÅÀ» ÇÇÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ÀÌ ¹æ¹ýÀº Ưº°ÇÑ ±â±¸¸¦ ÇÊ¿ä·Î ÇÏÁö ¾ÊÀ¸¸ç ¾î·Á¿ò ¾øÀÌ ÇÒ ¼ö ÀÖ´Â ÀåÁ¡µµ ÀÖÁö¸¸, ÇÇÀÓÀ̶ó´Â ¸ñÀû ¶§¹®¿¡ ¼º°¨À» Èñ»ýÇÏ°Ô µÇ´Â °æÇâÀÌ °­ÇÏ´Ù. ´õ¿íÀÌ °áÁ¤ÀûÀÎ °áÁ¡Àº ÀÓ½ÅÀÇ À§Çèµµ Å©´Ù´Â Á¡ÀÌ´Ù. ¡¼¿©¼ºÀÌ ±â±¸¸¦ »ç¿ëÇÏ´Â ¹æ¹ý¡½¨ç Æä¼­¸®
  • bite control
    ±³ÇÕ Á¶Á¤
    ±³ÇÕ°£ °ü°è³ª ±× Ç¥½Ã¸¦ Á¶Á¤ÇÏ´Â °Í.
  • case control study
    ȯÀÚ ´ëÁ¶ ¿¬±¸
  • control animal
    ´ëÁ¶ µ¿¹°
  • control equipment
    Á¦¾î ÀåÄ¡
  • control gene
    Á¦¾î À¯ÀüÀÚ
  • control of bleeding
    ÁöÇ÷¹ý
  • control panel
    Á¶Á¾ÆÇ
  • control system
    Á¶Àý°è
  • control valve
    Á¶Àý ¹ëºê, Á¶ÀýÆÇ
  • laser hazard control measure
    ·¹ÀÌÀú À§ÇØÁ¶Àý¹ý
    ·¹ÀÌÀú°¡ Áö´Ñ ¾öû³­ ¿¡³ÊÁö´Â ÀÎü¿¡ ÇØ°¡ µÉ ¼ö ÀÖÀ¸¹Ç·Î µÇµµ·Ï ·¹ÀÌÀú¸¦ »ç¿ëÇÏ´Â »ç¶÷µéÀÌ ¼Õ»óÀ» ¹ÞÁö ¾Êµµ·Ï ÇÏ´Â ¹æ¹ý.
  • leprosy control
    ³ª °ü¸®
    °³³ä»ó, ÁÖ¹ÎÀ» ³ª±ÕÀÇ Àü¿°À¸·ÎºÎÅÍ º¸È£ÇÏ´Â ¿¹¹æ °ü¸®¿Í, ³ªÈ¯ÀÚ¸¦ ³ª±ÕÀ¸·ÎºÎÅÍ ¿À´Â À°Ã¼Àû, Á¤½ÅÀû °íÅëÀ» ´ú¾î ÁÖ´Â Áø·á °ü¸®ÀÇ µÎ °¡Áö·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ¨ç ¿¹¹æ °ü¸®´Â Àü¿°¿øÀ» Â÷´ÜÇÏ´Â °ÍÀ» ¸»Çϴµ¥, ³ª ȯÀÚ¸¦ °Ý¸®ÇÔÀ¸·Î½á ³ªº´ÀÇ Àü¿°¿øÀÌ Â÷´ÜµÈ´Ù°í »ý°¢Çß´ø ½Ã´ë¿¡´Â ³ª ȯÀÚ Àü¿øÀ» °Ý¸® ¼ö¿ëÇÏ¿´´Ù. ±×·¯³ª Àüü ³ª ȯÀÚ Áß ±ØÈ÷ ÀϺÎÀÇ ¹Ì°ü¸®ÇÏ¿¡ Àִ ȯÀÚ¸¸ÀÌ Àü¿°¿øÀÌ µÈ´Ù´Â »ç½ÇÀÌ ¹àÇôÁø ¿À´Ã³¯¿¡´Â, ³ª ȯÀÚ·Î È®ÀÎÀÌ µÇ¾î ¾àÁ¦ Åõ¿©°¡ ½ÃÀÛµÈ ÈÄ¿¡´Â Àü¿°¿øÀÌ µÉ ¼ö ¾ø´Ù´Â °á·Ð¿¡ À̸£·¶´Ù. ÀÌ¿¡ µû¶ó ¿À´Ã³¯¿¡´Â ÀÏ¹Ý ÇǺΠÁúȯÀÚ¿Í °°ÀÌ ÀÚÀ¯·ÎÀÌ »ý¾÷¿¡ Á¾»çÇϸç Áø·á¸¦ ¹Þ°í ÀÖ´Ù. ¨è Áø·á °ü¸®´Â Àǻ簡 Á¤È®ÇÑ Áø´Ü°ú º´Çü ºÐ·ù¸¦ ¹ÙÅÁÀ¸·Î ÀûÇÕÇÑ Ã³¹æÀ» ³»¸®°í ȯÀÚ°¡ ¼º½ÇÇÏ°Ô ¾àÀ» º¹¿ëÇÏ´Â °ÍÀÌ´Ù. ¹®Á¦´Â ³ªº´ÀÌ ¸¸¼ºÀûÀ¸·Î °æ°úÇÏ´Â Àå±â ÁúȯÀε¥´Ù Ä¡·áÀÇ ¼º°ú°¡ Áï½Ã ³ªÅ¸³ªÁö ¾ÊÀ¸¹Ç·Î 󹿰ú º¹¾àÀÌ ³ªÅÂÇØÁ® Ä¡·á°¡ ºÒ±ÔÄ¢ÇØÁö°í ¾àÁ¦ ³»¼ºÀ» ¹ßÀü½ÃŰ´Â µ¥ µû¸¥ °ü¸®»óÀÇ ¾î·Á¿òÀÌ ÀÖ´Ù. ³ªº´¿¡ ´ëÇÑ Æí°ßÀ» ¾ø¾Ö°í ±¹¹ÎÀû ÀÌÇØ¿Í Âü¿©¿¡ ÀÇÇØ Á¶±â ¹ß°ß ¹× Ä¡·á¿¡ ÀÓÇÑ´Ù¸é ³ªº´ °ü¸®¸¦ À§ÇÑ Æ¯¼ö ½Ã¼³À̳ª ±â°üÀÌ ÇÊ¿ä¾ø°Ô µÉ °ÍÀÌ´Ù.
  • nociceptive control
    Ä§ÇØ ¼ö¿ë¼º Á¶Àý, À¯ÇØ ¼ö¿ë¼º Á¶Àý
  • pest control
    À¯ÇØ »ý¹° Á¦¾î
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
desensitization, allergy Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years.
(12 Dec 1998)
drug allergy Sensitivity (hypersensitivity) to a drug or other chemical.
(05 Mar 2000)
immediate allergy A type I allergic reaction; so called because in a sensitised subject the reaction becomes evident usually within minutes after contact with the allergen (antigen), reaches its peak within an hour or so, then rapidly recedes.
See: immediate reaction, anaphylaxis.
Compare: delayed allergy.
(05 Mar 2000)
immunotherapy, allergy Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellow jackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years.
(12 Dec 1998)
insulin allergy When a person's body has an allergic or bad reaction to taking insulin made from pork or beef or from bacteria, or because the insulin is not exactly the same as human insulin or because it has impurities. The allergy can be of two forms. Sometimes an area of skin becomes red and itchy around the place where the insulin is injected. This is called a local allergy. In another form, a person's whole body can have a bad reaction. This is called a systemic allergy. The person can have hives or red patches all over the body or may feel changes in the heart rate and in the rate of breathing. A doctor may treat this allergy by prescribing purified insulins or by desensitisation.
See: desensitisation.
(09 Oct 1997)
test, skin, for allergy A test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable.
(12 Dec 1998)
latent allergy Allergy that causes no signs or symptoms but can be revealed by means of certain immunologic tests with specific allergens.
(05 Mar 2000)
accessory symptom A symptom that usually but not always accompanies a certain disease, as distinguished from a pathognomonic symptom.
Synonym: assident symptom, concomitant symptom.
(05 Mar 2000)
accidental symptom Any morbid phenomenon coincidentally occurring in the course of a disease, but having no relation with it.
(05 Mar 2000)
assident symptom A symptom that usually but not always accompanies a certain disease, as distinguished from a pathognomonic symptom.
Synonym: assident symptom, concomitant symptom.
(05 Mar 2000)
Baumes symptom Pain behind the sternum in angina pectoris.
(05 Mar 2000)
Bezold's symptom Inflammatory oedema at the tip of the mastoid process in mastoiditis.
Synonym: Bezold's sign.
(05 Mar 2000)
Bolognini's symptom A feeling of crepitation on gradually increasing pressure on the abdomen in cases of measles.
Cardinal symptom, the primary or major symptom of diagnostic importance.
(05 Mar 2000)
Macewen's symptom <clinical sign> Percussion of the skull gives a cracked-pot sound in cases of hydrocephalus.
Synonym: Macewen's symptom.
(05 Mar 2000)
rainbow symptom A yellowish white ring surrounding the optic disk, indicating atrophy of the choroid in glaucoma.
Synonym: glaucomatous ring.
A halo surrounding lights, caused by corneal oedema in glaucoma.
Synonym: rainbow symptom.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conception control
    ¼öÅ Á¶Àý;ÇÇÀÓ
  • control
    Áö¹è;´Ü¼Ó;°ü¸®;°¨µ¶(±Ç);¾ïÁ¦;Á¦¾î;±ÔÁ¦;Á¦±¸(·Â);ÄÁÆ®·Ñ;ÅëÁ¦(°üÁ¦)¼ö´Ü;(±â°èÀÇ)Á¶Á¾(Á¦¾î)ÀåÄ¡;(½ÇÇèÀÇ)´ëÁ¶Ç¥ÁØ;´ëÁ¶±¸;¿µ¸Å¸¦ Áö¹èÇÏ´Â Áö¹è·É;(ÀÚµ¿Â÷°æÁֵ¼­ °£´ÜÇÑ ¼ö¸®¸¦ À§ÇÑ)°æÁÖ Áߴܱ¸¿ª;Á¦¾î;Áö¹èÇÏ´Ù;ÅëÁ¦(°üÁ¦)ÇÏ´Ù;°¨µ¶ÇÏ´Ù;°ü¸®ÇÏ´Ù;¾ïÁ¦(Á¦¾î)ÇÏ´Ù;(
  • control board
    Á¦¾î¹Ý
  • control booth
    (¶óµð¿À.TV)Á¦¾î½Ç;Á¶Á¤½Ç
  • control chart
    °ü¸®µµ(ƯÈ÷ Á¦Ç° ǰÁúÀÇ)
  • control clock
    ±âÁØ ½Ã°è(master clock)
  • control column
    Á¶Á¾·û(Â÷ÀÇ ÇÚµé½Ä Á¶Á¤°£)
  • control experiment
    ´ëÁ¶ ½ÇÇè
  • control grid
    (ÀüÀÚ°üÀÇ)Á¦¾î ±×¸®µå(°ÝÀÚ)
  • control group
    Á¦¾îÁý´Ü;Á¶Á¾ÀåÄ¡;´ëÁ¶±º(µ¿ÀϽÇÇè¿¡¼­ ½ÇÇè¿ä°ÇÀ» °¡ÇÏÁö ¾ÊÀº ±×·ì)
  • control lever
    =CONTROL STICK
  • control panel
    =CONTROL BOARD
  • control rod
    (¿øÀÚ·ÎÀÇ)Á¦¾îºÀ
  • control room
    °üÁ¦½Ç;(¿øÀڷ½ü³µîÀÇ)Á¦¾î½Ç;(¹æ¼Û±¹µîÀÇ)Á¶Á¤½Ç
  • control stick
    Á¶Á¾°£
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á